Literature DB >> 26886381

Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease.

Bhavadharini Ramu1, Thenappan Thenappan2.   

Abstract

Pulmonary hypertension associated with left heart disease is the most common form of pulmonary hypertension. Although its pathophysiology remains incompletely understood, it is now well recognized that the presence of pulmonary hypertension is associated with a worse prognosis. Right ventricular failure has independent and additive prognostic value over pulmonary hypertension for adverse outcomes in left heart disease. Recently, several new terminologies have been introduced to better define and characterize the nature and severity of pulmonary hypertension. Several new treatment options including the use of pulmonary arterial hypertension specific therapies are being considered, but there is lack of evidence. Here, we review the recent advances in this field and summarize the diagnostic and therapeutic modalities of use in the management of pulmonary hypertension associated with left heart disease.

Entities:  

Keywords:  Diastolic pulmonary gradient; Heart failure; Hemodynamics; Left heart disease; Pulmonary arterial compliance; Pulmonary hypertension; Right ventricular dysfunction

Mesh:

Year:  2016        PMID: 26886381     DOI: 10.1007/s11897-016-0284-x

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  104 in total

1.  Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure.

Authors:  Jaroslav Meluzin; Lenka Spinarová; Petr Hude; Jan Krejcí; Vladimír Kincl; Roman Panovský; Ladislav Dusek
Journal:  J Am Soc Echocardiogr       Date:  2005-05       Impact factor: 5.251

Review 2.  Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases.

Authors:  Jocelyn Dupuis; Marco Guazzi
Journal:  Can J Cardiol       Date:  2014-10-14       Impact factor: 5.223

3.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

4.  Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).

Authors:  Thomas F Lüscher; Frank Enseleit; Richard Pacher; Veselin Mitrovic; Matthias R Schulze; Roland Willenbrock; Rainer Dietz; Valentin Rousson; David Hürlimann; Sebastian Philipp; Thomas Notter; Georg Noll; Frank Ruschitzka
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

5.  The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease.

Authors:  Emmanouil Tampakakis; Peter J Leary; Van N Selby; Teresa De Marco; Thomas P Cappola; G Michael Felker; Stuart D Russell; Edward K Kasper; Ryan J Tedford
Journal:  JACC Heart Fail       Date:  2014-11-12       Impact factor: 12.035

6.  Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management.

Authors:  D L Moraes; W S Colucci; M M Givertz
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

7.  Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study.

Authors:  Milton Packer; John McMurray; Barry M Massie; Abraham Caspi; Vincent Charlon; Alain Cohen-Solal; Wolfgang Kiowski; William Kostuk; Henry Krum; Barry Levine; Paolo Rizzon; Jordi Soler; Karl Swedberg; Susan Anderson; David L Demets
Journal:  J Card Fail       Date:  2005-02       Impact factor: 5.712

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

9.  Pilot assessment of the response of several pulmonary hemodynamic variables to sublingual sildenafil in candidates for heart transplantation.

Authors:  Miguel Angel Gómez-Sánchez; Carlos Saenz De La Calzada; Pilar Escribano Subías; Juan Francisco Delgado Jiménez; María Lázaro Salvador; Agustín Albarrán González; Luis Cea Calvo
Journal:  Eur J Heart Fail       Date:  2004-08       Impact factor: 15.534

10.  Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients.

Authors:  Andreas P Kalogeropoulos; Sarawut Siwamogsatham; Salim Hayek; Song Li; Anjan Deka; Catherine N Marti; Vasiliki V Georgiopoulou; Javed Butler
Journal:  J Am Heart Assoc       Date:  2014-02-03       Impact factor: 5.501

View more
  4 in total

1.  Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.

Authors:  Jennifer L Philip; Thomas M Murphy; David A Schreier; Sydney Stevens; Diana M Tabima; Margie Albrecht; Andrea L Frump; Timothy A Hacker; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-15       Impact factor: 4.733

Review 2.  On the right side of the heart: Medical and mechanical support of the failing right ventricle.

Authors:  Ignacio de Asua; Alex Rosenberg
Journal:  J Intensive Care Soc       Date:  2017-01-03

3.  Serum biomarker analysis at the protein level on pulmonary hypertension secondary to old anterior myocardial infarction.

Authors:  Xiangqi Wu; Wei You; Zhiming Wu; Fei Ye; Shaoliang Chen
Journal:  Pulm Circ       Date:  2020-11-25       Impact factor: 3.017

4.  Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients.

Authors:  Julio D Duarte; Mayank Kansal; Ankit A Desai; Katherine Riden; Meghan J Arwood; Alex A Yacob; Thomas D Stamos; Larisa H Cavallari; Roham T Zamanian; Sanjiv J Shah; Roberto F Machado
Journal:  Pulm Circ       Date:  2018 Apr-Jun       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.